Cuba will start this month a broader intervention study with the vaccine candidates Abdala and Soberana 02, prioritizing complex territories and risk groups. Then, after the approval of the emergency use, the island will increase the scope of immunization, and by August, 70% of its population will be vaccinated.
Cuba's Soberana Plus vaccine candidate against Covid-19 is currently showing encouraging results by considerably raising antibodies in Covid-19 convalescents with only one dose.
The province of Holguín prepares the conditions to begin in the next few days the intervention with the vaccine candidate Abdala in risk groups, specifically with health workers, students of Medical Sciences and other vulnerable people in the territory.
A project to determine the genetic predisposition of patients with Spinocerebellar Ataxia type II (SCA2) to suffer from COVID-19 is being developed by specialists from Holguín, the Cuban province with the highest prevalence of this disease.